Clinical Trials Logo

Clinical Trial Summary

to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering.


Clinical Trial Description

The impact of the progesterone level at the end of the follicular phase in stimulated IVF/ICSI cycles and its effect on the pregnancy rate and oocyte quality is controversial, which arises from conflicting results in retrospective studies and meta-analyses. This study is assumed to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering. If variation is present, the impact of variation on the developing oocyte and embryo quality will be estimated by embryo quality indicators. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03519776
Study type Observational
Source IVI Middle East Fertility Clinic
Contact
Status Completed
Phase
Start date May 10, 2018
Completion date March 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT03356964 - Step Down FSH Approach and Late Follicular Phase in Progesterone Level Early Phase 1
Recruiting NCT06390904 - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients Phase 2/Phase 3
Recruiting NCT05316935 - GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients Phase 2/Phase 3
Recruiting NCT06379113 - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients Phase 2/Phase 3
Completed NCT03930212 - Progesterone Supplementation in Threatened Abortion Phase 4
Completed NCT05062135 - Progesterone Action on Endometrium of PCOS N/A